期刊文献+

74例早发性乳腺癌患者BRCA1和BRCA2基因致病突变研究 被引量:3

BRCA1 and BRCA2 pathogenic mutations in 74 patients with early-onset breast cancer
原文传递
导出
摘要 目的研究乳腺癌易感基因BRCA1和BRCA2在早发性乳腺癌(确诊年龄≤35岁)患者中突变情况,分析致病突变与临床特征之间关系。方法选择2014年9月至2016年6月期间就诊于军事医学科学院附属医院的早发性乳腺癌患者74例,采用高通量二代测序技术以及生物信息分析,对纳入患者BRCA1和BRCA2基因的49个外显子序列及拼接区序列进行检测分析,并将患者按临床特征分组,X^2检验比较BRCA1和BRCA2致病突变在各组的分布。结果在74例早发性乳腺癌患者中,检测到15例(20.27%)BRCA1/2致病突变,包括5例(6.76%)BRCA1致病突变,10例(13.51%)BRCA2致病突变。其中11例为新发现致病突变,检测到1例患者携带相对高频致病基因突变BRCA1∶c.5470_5477delTGCCCAAT。有乳腺癌或卵巢癌家族史组携带致病突变率明显高于无家族史组(40.91%vs 11.54%,X^2=6.534,P=0.011)。结论 BRCA1/2致病突变对早发性乳腺癌意义重大,尤其是伴有乳腺癌或卵巢癌家族史的早发性乳腺癌。新发现的致病突变可能为中国人群特有突变。BRCA1∶c.5470_5477delTGCCCAAT可能成为中国人群的始祖突变。 Objective To investigate the pathogenic mutations of BRCA1 and BRCA2 in patients with early-onset breast cancer( ≤35 years) and explore the relationships between BRCA1/2 mutations and clinical features. Methods Seventy-four patients with early-onset breast cancer were enrolled, who were treated in Hospital 307 between September 2014 and June 2016. High-throughput sequencing was used to test the 49 exon sequences and adjacent sequences of BRCA1 and BRCA2. χ2 test was used to analyze the distribution of BRCA1/2 pathogenic mutations in each group that was set up according to clinical features. Results Fifteen mutations(20.27% ) were identified, including 5(6.76% ) in BRCA1 and 10 ( 13.51% ) in BRCA2. Eleven new pathogenic mutations were discovered, and BRCA1 : c. 5470_5477delTGCCCAAT was found in one patient. The frequency of BRCA1/2 mutations in the group with a family history of breast cancer or ovarian cancer was higher than in the group without a family history (40.91% vs 11. 54% ) (Z2 = 6. 534, P = 0. 011 ). Conclusion BRCA1/2 pathogenic mutation is significant for early-onset breast cancer, especially for those with a family history of breast or ovarian cancer. The new mutations may be specific to Chinese people. BRCA1 : c. 5470_ 5477delTGCCCAAT may be the ancestor mutation among the Chinese.
出处 《军事医学》 CSCD 北大核心 2017年第5期398-401,共4页 Military Medical Sciences
基金 中国健康促进基金 军事医学科学院创新基金资助项目(2013ZHYX012)
关键词 乳腺肿瘤 乳腺癌易感基因1 乳腺癌易感基因2 突变 breast neoplasms BRCA1 BRCA2 mutation
  • 相关文献

参考文献6

二级参考文献73

  • 1宋传贵,胡震,袁文涛,狄根红,沈镇宙,黄薇,邵志敏.中国上海家族性乳腺癌BRCA1和BRCA2基因的突变[J].中华医学遗传学杂志,2006,23(1):27-31. 被引量:29
  • 2张宏艳,刘端祺,范萍,黄其敏,侯新燕,彭雁,矫健,吕楠.乳腺癌普查初步报道及资料分析[J].解放军医学杂志,2007,32(6):654-654. 被引量:49
  • 3杨黎,朱霞,冉立.HER-2、PCNA、Bcl-2、Bax在乳腺癌组织中的表达与预后的关系[J].癌症,2007,26(7):756-761. 被引量:17
  • 4Scully R, Livingston DM. In search of the tuner-suppressor functions of BRCA1 and BRCA2. Nature, 2000, 408:429-432.
  • 5Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med, 1997, 336: 1401-1408.
  • 6Abeliovich D, Kaduri L, Lerer I, et al. The fotmder mutations 185delAG and 5382insC in BRCA1 and 6174delT inBRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet, 1997, 60:505-514.
  • 7Johannesdottir G, Gudmundsson J, Bergthorsson JT, et al. High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. Cancer Res, 1996, 56:3663-3665.
  • 8Peelen T, Vliet MA, Petrij-Bosch A, et al. A high proportion of novel mutations in BRCA1 with strong fotmder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet, 1997, 60: 1041-1049.
  • 9Tereschenko IV, Basham VM, Ponder BAJ, et al. BRCA1 and BRCA2 mutations in Russian familial breast cancer. Hum Mutat, 2002, 19: 184.
  • 10Gorski B, Jakubowska A, Huzarski T, et al. A high proportion of founder BRCA1 mutations in Polish breast cancer families. Ira J Cancer, 2004, 110:683-686.

共引文献56

同被引文献31

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部